Wirkung von Candesartan cilexetil auf den Glukosestoffwechsel
Author:
Trenkwalder Peter
Reference19 articles.
1. Chow L, De Gasparo M, Levens N (1995) Improved glucose metabolism following blockade of angiotensin converting enzyme but not angiotensin ATI receptors. Europ J Pharmacol 282: 77–86
2. Delacrétaz E, Nussberger J, Biollaz J, Waeber B, Brunner HR (1995) Characterization of the angiotensin II receptor antagonist TCV-116 in healthy volunteers. Hypertension 25: 14–21
3. Ferrari P, Rosman J, Weidmann P (1991) Antihypertensive agents, serum lipoproteins and glucose metabolism. Am J Cardiol 67: 26B–35B
4. Goa KL, Wagstaff AJ (1996) Losartan potassium: A review of its pharmacology, clinical efficacy and tolerability in the management of hypertension. Drugs 51: 820–845
5. Herings RM, de Boer A, Strieker BH, Leufkens HG, Porsius A (1995) Hypoglyeaemia associated with use of inhibitors of angiotensin converting enzyme. Lancet 345: 1195–1198